Page last updated: 2024-10-29

ifosfamide and Carcinomatous Meningitis

ifosfamide has been researched along with Carcinomatous Meningitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
" TOPO dosage was 3."1.37Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors. ( Kiewe, P; Korfel, A; Reinwald, M; Thiel, E, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kiewe, P1
Thiel, E1
Reinwald, M1
Korfel, A1
Onesti, E1
Fabi, A1
Mingoia, M1
Savarese, A1
Anelli, V1
Koudriavtseva, T1

Reviews

1 review available for ifosfamide and Carcinomatous Meningitis

ArticleYear
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O

2012

Other Studies

1 other study available for ifosfamide and Carcinomatous Meningitis

ArticleYear
Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:3

    Topics: Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Female; Humans; Ifosfamid

2011